Combining Clarivate’s robust proprietary data with extensive bespoke consulting and custom research capabilities, we develop nuanced, defendable assessments and strategies to help biopharmaceutical and MedTech clients make better, more informed decisions in a rapidly changing landscape.

By harnessing deep domain knowledge, proprietary data sets, and broad methodological capabilities, we provide innovative problem-solving approaches to biopharma and Medtech’s toughest challenges. Our pioneering insight-enabled consulting model sets us apart, empowering us to focus on co-creation, thought partnership, and custom solutions.​

arrow_forwardMeet our Commercial Strategy experts

New product and portfolio strategy

Developing an approach that maximizes product and portfolio impact requires a detailed, nuanced understanding of disease area and industry dynamics.  Backed by deep domain knowledge and extensive experience from proof of concept through lifecycle management, our team delivers strategic, data-driven recommendations to support clinical development, enable effective product positioning, and fuel successful market adoption.​

Offerings include: ​

  • Market sizing & landscape assessment
  • Therapy area strategy
  • Indication prioritization
  • Portfolio optimization & prioritization
  • Asset, market, and therapy area opportunity assessments
  • Forecasting & valuation
  • Clinical value & product positioning/differentiation strategy
  • Patient journey mapping
  • Growth & value maximization strategy
  • Commercial due diligence and investment decision support

Global pricing and access​ strategy

Critical to the commercial success of a product is a detailed understanding of its market access potential.  Our team’s extensive experience and proprietary data assets enable us to guide you through the evolving complexities of global reimbursement markets with thoughtful consideration of the unique dynamics at play.

​Offerings include:​

  • Market sizing and access journey​
  • Access landscape assessment
  • Evidence generation strategy​
  • BD&L access due diligence​
  • Pricing, contracting, and RWE strategy
  • Stakeholder engagement planning​
  • Indication prioritization​
  • Account engagement strategy​
  • External payer/KOL validation​
  • TPP testing and refinement​
  • Payer value proposition and messaging strategy
  • Payer archetyping and segmentation​
  • Launch framework optimization ​
  • Early access program support​
  • Emerging markets planning​

Check out our latest webinars

Customer Case Study – SPRIND

German federal agency SPRIND turned to Clarivate for assistance in evaluating potential investments in breakthrough innovations, particularly in the field of biotech. We provided expertise in life sciences, intellectual property, and oncology, and produced comprehensive market assessment reports for key oncology indications. With our help, SPRIND was able to confidently invest in projects with high potential for improving the quality of life for people in Germany and around the world.

arrow_forwardRead more

Our latest thought leadership

Hi, I'm Eric Persoff.

I am head of Japan and APAC – commercial strategy consulting at Clarivate. We’d love to hear from you and see how we can help provide insight across your drug and device lifecycle.

Learn more about my expertise or get in touch by clicking below.

Get in touch